Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCH 527123 in Severe Asthma
NCT01006161Phase 2Withdrawn
- Sponsor
- Merck & Co.
- Start
- Jan 2010
- Primary completion
- Aug 2012
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of navarixin in asthma, sponsored by Merck & Co.. Planned start Jan 2010; status: withdrawn.
02
Drugs
navarixin
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01006161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01006161.